Skip to main content
. Author manuscript; available in PMC: 2016 Aug 3.
Published in final edited form as: JCI Insight. 2016 Jul 7;1(10):e86673. doi: 10.1172/jci.insight.86673

Figure 2. Prophylactic efficacy of H3v-104, H3v-126, and H3v-71 in mice.

Figure 2

Groups of mice (n = 5) were treated with 100 μg of individual mAbs 24 hours before challenge with mouse-adapted A/Minnesota/11/2010 X203 virus. Controls (n = 10) were injected with PBS. The weight loss of mice was measured daily for 14 days after inoculation (day 0).